Medgene Labs has been working on a solution to RHDV2 since the 2020 outbreak. Recently granted emergency-use authorization by the USDA, the vaccine uses genetically modified cells that are injected so that the body creates the proteins.
Medgene Labs has been working on a solution to RHDV2 since the 2020 outbreak. Recently granted emergency-use authorization by the USDA, the vaccine uses genetically modified cells that are injected so that the body creates the proteins.